Cellular Immunity in Systemic Lupus Erythematosus As Evidenced in Vitro by Leucocyte Migration Inhibition Tests

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 1977 Oct 1

PMID 921343

Authors

M Okubo

Y Nagura

D Pompa

G Treser

K Lange

Affiliations

Soon will be listed here.

Abstract

A leucocyte migration inhibition test was performed on 26 patients with systemic lupus erythematosus (SLE) and on 35 control subjects using three different antigens, fetal calf thymus DNA, baker's yeast RNA, and calf thymus extractable nuclear antigen (ENA). Leucocyte migration was inhibited by DNA in 17 out of 26 SLE patients (65-3%), and in only 2 of the 35 controls (5-7%). When RNA or ENA was added none of the patients or controls showed inhibition. In SLE patients migration inhibition by DNA was significantly correlated with the presence of proteinuria and/or granular casts in urinary sediment. When the migration inhibition test was positive, immunofluorescence verified active histology of the glomeruli obtained by a percutaneous renal biopsy.

References

ORES R, Lange K . SKIN TEST FOR THE DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS. Am J Med Sci. 1964; 248:562-6. DOI: 10.1097/00000441-196411000-00007. View

Stollar D, Levine L, MARMUR J . Antibodies to enatured deoxyribonucleic acid in lupus erythematosus serum. II. Characterization of antibodies in several sera. Biochim Biophys Acta. 1962; 61:7-18. DOI: 10.1016/0926-6550(62)90023-3. View

Lange K, Wasserman E, SLOBODY L . The significance of serum complement levels for the diagnosis and prognosis of acute and subacute glomerulonephritis and lupus erythematosus disseminatus. Ann Intern Med. 1960; 53:636-46. DOI: 10.7326/0003-4819-53-4-636. View

Riggs J, Loh P, EVELAND W . A simple fractionation method for preparation of fluorescein-labeled gamma globulin. Proc Soc Exp Biol Med. 1960; 105:655-8. DOI: 10.3181/00379727-105-26207. View

HOLMAN H, DEICHER H, KUNKEL H . The L. E. cell and the L. E. serum factors. Bull N Y Acad Med. 1959; 35(7):409-18. PMC: 1806184. View

DEICHER H, HOLMAN H, KUNKEL H . The precipitin reaction between DNA and a serum factor in systemic lupus erythematosus. J Exp Med. 1959; 109(1):97-114. PMC: 2136932. DOI: 10.1084/jem.109.1.97. View

LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

Sharp G, Irvin W, Tan E, Gould R, HOLMAN H . Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972; 52(2):148-59. DOI: 10.1016/0002-9343(72)90064-2. View

Galanaud P, Dormont J, CROSNIER J, Mery J . Leucocyte-migration test in seronegative S.L.E. Lancet. 1971; 2(7730):923. DOI: 10.1016/s0140-6736(71)92528-1. View

10.

Moulias R, Goust J, Reinert P, DEVILLECHABROLLE A, Muller Berat C, Hereman C . [The leukocyte migration test in the presence of DNA during disseminated lupus erythematosus]. Nouv Presse Med. 1972; 1(21):1403-7. View

11.

Hughes G . Significance of anti-D.N.A. antibodies in systemic lupus erythematosus. Lancet. 1971; 2(7729):861-3. DOI: 10.1016/s0140-6736(71)90234-0. View

12.

Federlin K, Helmke K . Depression of cellular hypersensitivity to D.N.A. in systemic lupus erythematosus. Lancet. 1972; 1(7750):596-7. DOI: 10.1016/s0140-6736(72)90393-5. View

13.

Koffler D, Schur P, KUNKEL H . Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med. 1967; 126(4):607-24. PMC: 2138388. DOI: 10.1084/jem.126.4.607. View

14.

McCluskey R, Vassalli P, Gallo G, Baldwin D . An immunofluorescent study of pathogenic mechanisms in glomerular diseases. N Engl J Med. 1966; 274(13):695-701. DOI: 10.1056/NEJM196603312741301. View

15.

Podleski W, Podleski U . Circulating sensitized lymphocytes in systemic lupus erythematosus. Nature. 1973; 241(5387):278-9. DOI: 10.1038/241278a0. View

16.

Messner R, Lindstrom F, Williams Jr R . Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus. J Clin Invest. 1973; 52(12):3046-56. PMC: 302579. DOI: 10.1172/JCI107503. View

17.

Hahn B, Bagby M, Osterland C . Disparity between humoral and cellular immune responses to desoxyribonucleic acid in systemic lupus erythematosus. Am J Med Sci. 1973; 266(3):193-201. DOI: 10.1097/00000441-197309000-00005. View

18.

Williams Jr R, DeBoard J, Mellbye O, Messner R, Lindstrom F . Studies of T- and B-lymphocytes in patients with connective tissue diseases. J Clin Invest. 1973; 52(2):283-95. PMC: 302257. DOI: 10.1172/JCI107184. View

19.

Abe T, Hara M, Yamasaki K, Homma M . Cell-mediated immune response in systemic lupus erythematosus. In vitro cellular response to native DNA by macrophage inhibitory test. Arthritis Rheum. 1973; 16(5):688-94. DOI: 10.1002/art.1780160514. View

20.

Goldman J, Litwin A, Adams L, KRUEGER R, Hess E . Cellular immunity to nuclear antigens in systemic lupus erythematosus. J Clin Invest. 1972; 51(10):2669-77. PMC: 332966. DOI: 10.1172/JCI107085. View